Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinoma.
Kai OzakiShingo HatakeyamaTomoko HamayaKazutaka OkitaYasuhiro HashimotoChikara OhyamaPublished in: International journal of urology : official journal of the Japanese Urological Association (2021)